Skip to main content
. 2015 Aug 12;34(3):154–159. doi: 10.1016/j.krcp.2015.07.005

Table 2.

Laboratory findings at admission

Variables Nonsurvivor (n=451) Survivor (n=2,241) P
PaO2 (mmHg) 96.7±59.2 86.5±49.2 <0.001
HCO3 (mmol/L) 18.3±6.8 18.3±6.8 0.930
White blood cell (103/mm3) 14.0±17.2 9.9±7.5 <0.001
Hemoglobin (g/dL) 10.6±2.6 9.9±3.2 <0.001
AST (U/L) 240.4±1,760.7 106.9±914.0 0.118
ALT (U/L) 97.3±371.7 59.1±326.2 0.043
Total bilirubin (mg/dL) 1.6±3.6 0.9±1.5 <0.001
Direct bilirubin (mg/dL) 1.2±1.8 0.8±2.2 0.017
Albumin (g/dL) 3.1±1.2 3.4±1.1 <0.001
Blood urea nitrogen (mg/dL) 47.1±35.5 71.4±48.5 <0.001
Creatinine (mg/dL) 3.4±3.0 7.8±6.0 <0.001
Sodium (mEq/L) 135.2±7.9 134.8±8.4 0.333
Potasssium (mEq/L) 4.5±1.1 5.5±4.7 0.087
PT (INR) 1.4±0.8 1.3±0.5 0.338
Lactate dehydrogenase (U/L) 1,311.2±3,036.7 704.7±1,430.0 <0.001
C-reactive protein (mg/dL) 9.5±9.5 5.6±17.6 <0.001
Inorganic phosphate (mg/dL) 4.7±2.3 5.6±15.5 0.214
Total calcium (mg/dL) 7.2±2.0 7.1±2.6 0.258
Low-density lipoprotein (mg/dL) 84.6±45.7 97.4±40.9 0.003
Proteinuria 295 (65.4) 1,615 (72.1) <0.001
Hematuria 383 (84.9) 1,734 (77.3) 0.263

Data are presented as mean ± SD or n (%).

AST, aspartate transaminase; ALT, alanine transaminase; INR, international normalized ratio; PT, prothrombin time.